Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (681-690 of 706) with videos related to

Pageof 71
Sort By:
The American Journal of Geriatric Cardiology|June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the ElderlyCharles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
American Journal of Nephrology|December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsMeg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.
Journal of the American College of Cardiology|February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trialKenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 8, 2023
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical TrialTae Won Yi, Brendan Smyth, Gian Luca Di Tanna, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 4, 2015
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trialsGiuseppe Patti, Rachel Bennett, Sreenivasa Rao Kondapally Seshasai, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
Cardiovascular Diabetology|June 16, 2026
Prognostic Value of Coronary CT Angiography Among Patients With and Without Diabetes: The Mass General Brigham CCTA registryArthur Shiyovich, Daniel M Huck, Rhanderson Cardoso, et al.
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 23, 2021
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary AnalysisMeg Jardine, Zien Zhou, Hiddo J Lambers Heerspink, et al.
Journal of the American College of Cardiology|February 28, 2024
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular DiseaseAdam N Berman, David W Biery, Stephanie A Besser, et al.
Pageof 71

Showing results (681-690 of 706) with videos related to

Sort By:
Pageof 71
The American Journal of Geriatric Cardiology|June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the ElderlyCharles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
American Journal of Nephrology|December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsMeg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.
Journal of the American College of Cardiology|February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trialKenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 8, 2023
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical TrialTae Won Yi, Brendan Smyth, Gian Luca Di Tanna, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 4, 2015
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trialsGiuseppe Patti, Rachel Bennett, Sreenivasa Rao Kondapally Seshasai, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
Cardiovascular Diabetology|June 16, 2026
Prognostic Value of Coronary CT Angiography Among Patients With and Without Diabetes: The Mass General Brigham CCTA registryArthur Shiyovich, Daniel M Huck, Rhanderson Cardoso, et al.
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 23, 2021
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary AnalysisMeg Jardine, Zien Zhou, Hiddo J Lambers Heerspink, et al.
Journal of the American College of Cardiology|February 28, 2024
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular DiseaseAdam N Berman, David W Biery, Stephanie A Besser, et al.
Pageof 71